Last updated on June 2019

Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth

Brief description of study

The current study investigates the feasibility and safety of allogeneic mesenchymal stem/stromal cells in previous oropharynx cancer patients with radiation-induced hyposalivation and xerostomia

Detailed Study Description

Hyposalivation and xerostomia are the most common long-term side effects to radiotherapy of head and neck cancers.

A randomized clinical trial indicates that autologeous mesenchymal stem/stromal cells can restore function of the submandibular glands.

Patients with previous oropharynx cancer and radiation-induced hyposalivation and xerostomia will be treated with culture expanded adipose tissue derived mesenchymal stem/stromal cells from healthy donors.

The patients will be followed for 4 months for safety and efficacy registration

Clinical Study Identifier: NCT03874572

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.